Micron Technology To Rally Over 15%? Here Are 10 Top Analyst Forecasts For Friday
Portfolio Pulse from Avi Kapoor
Several top Wall Street analysts have updated their price targets and ratings for various US-listed companies. B of A Securities raised Micron Technology's target from $77 to $95 and upgraded the stock to Buy, causing a 3% rise in shares. Wells Fargo lowered bluebird bio's target from $8 to $5 but maintained an Equal-Weight rating, with shares up 8.6%. Deutsche Bank increased L3Harris Technologies' target from $184 to $240 and upgraded to Buy, despite a 0.7% share drop. B of A Securities also raised Intel's target from $32 to $50 and upgraded to Neutral, with shares up 1.4%. Oppenheimer reduced Apellis Pharmaceuticals' target from $88 to $75 but kept an Outperform rating, after a 17% share drop. MoffettNathanson raised Roku's target from $64 to $66 but downgraded to Sell, with shares up 1.2%. Wells Fargo increased General Electric's target from $115 to $144 and upgraded to Overweight, with a 0.1% share gain. Needham raised Coherent's target from $46 to $52 with a Buy rating, and shares rose 4.4%. Telsey Advisory Group increased NIKE's target from $128 to $140 with an Outperform rating, despite a 0.1% share fall. Lastly, Keybanc raised Tempur Sealy International's target from $48 to $56 with an Overweight rating, leading to a 3.2% share increase.
December 15, 2023 | 1:15 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Needham raised Coherent's price target from $46 to $52 with a Buy rating, leading to a 4.4% share increase.
The raised price target and Buy rating could maintain the positive momentum in the stock's short-term price movement.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
Wells Fargo upgraded General Electric to Overweight and raised the target from $115 to $144, with a minor 0.1% share gain.
The upgrade and significant target increase are positive signals that could contribute to a short-term upward price trend.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 85
POSITIVE IMPACT
B of A Securities upgraded Intel from Underperform to Neutral and increased the target from $32 to $50, with shares up 1.4%.
The upgrade to Neutral and the higher price target could lead to continued investor interest and a positive short-term price trend.
CONFIDENCE 80
IMPORTANCE 80
RELEVANCE 85
POSITIVE IMPACT
Deutsche Bank upgraded L3Harris Technologies to Buy and raised the target from $184 to $240, though shares fell 0.7%.
The upgrade and raised price target indicate a positive outlook, which could lead to a rebound in the short term despite the recent dip.
CONFIDENCE 75
IMPORTANCE 75
RELEVANCE 80
POSITIVE IMPACT
B of A Securities upgraded Micron Technology from Neutral to Buy and raised the price target from $77 to $95, resulting in a 3% share price increase.
The upgrade by B of A Securities and the significant increase in price target are likely to instill investor confidence and could lead to a continued positive short-term price movement.
CONFIDENCE 80
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Telsey Advisory Group increased NIKE's target from $128 to $140 with an Outperform rating, despite a slight share fall.
The increased price target and positive rating suggest a favorable outlook that could lead to a short-term recovery in share price.
CONFIDENCE 70
IMPORTANCE 65
RELEVANCE 70
POSITIVE IMPACT
Keybanc raised Tempur Sealy International's target from $48 to $56 with an Overweight rating, and shares rose 3.2%.
The target increase and positive rating could continue to drive investor interest and support a positive short-term price direction.
CONFIDENCE 75
IMPORTANCE 70
RELEVANCE 80
NEUTRAL IMPACT
Wells Fargo lowered bluebird bio's price target from $8 to $5 but maintained an Equal-Weight rating. Shares still gained 8.6%.
The reduction in price target is negative, but the maintenance of an Equal-Weight rating and the recent share price increase suggest a neutral short-term impact.
CONFIDENCE 70
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
Oppenheimer maintained an Outperform rating on Apellis Pharmaceuticals but cut the target from $88 to $75, after a 17% share drop.
The significant share price drop and reduced price target suggest a negative short-term impact, despite the Outperform rating.
CONFIDENCE 75
IMPORTANCE 85
RELEVANCE 80
NEGATIVE IMPACT
MoffettNathanson downgraded Roku to Sell but raised the target from $64 to $66, with shares up 1.2%.
The downgrade to Sell could overshadow the minor target increase, potentially leading to a negative short-term impact.
CONFIDENCE 70
IMPORTANCE 70
RELEVANCE 75